South Korea · Delayed Price · Currency is KRW NH Nongwoobio Statistics
Total Valuation
NH Nongwoobio has a market cap or net worth of KRW 113.18 billion. The enterprise value is 103.38 billion.
| Market Cap | 113.18B |
| Enterprise Value | 103.38B |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
NH Nongwoobio has 16.03 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 16.03M |
| Shares Outstanding | 16.03M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 0.18% |
| Float | 6.73M |
Valuation Ratios
The trailing PE ratio is 8.73.
| PE Ratio | 8.73 |
| Forward PE | n/a |
| PS Ratio | 0.71 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | 19.59 |
| P/OCF Ratio | 12.86 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.05, with an EV/FCF ratio of 17.90.
| EV / Earnings | 7.97 |
| EV / Sales | 0.64 |
| EV / EBITDA | 6.05 |
| EV / EBIT | 9.62 |
| EV / FCF | 17.90 |
Financial Position
The company has a current ratio of 3.78, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.78 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.51 |
| Debt / FCF | 4.48 |
| Interest Coverage | 10.99 |
Financial Efficiency
Return on equity (ROE) is 4.59% and return on invested capital (ROIC) is 3.46%.
| Return on Equity (ROE) | 4.59% |
| Return on Assets (ROA) | 1.91% |
| Return on Invested Capital (ROIC) | 3.46% |
| Return on Capital Employed (ROCE) | 3.56% |
| Weighted Average Cost of Capital (WACC) | 6.33% |
| Revenue Per Employee | 482.06M |
| Profits Per Employee | 38.93M |
| Employee Count | 333 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 0.71 |
Taxes
In the past 12 months, NH Nongwoobio has paid 1.55 billion in taxes.
| Income Tax | 1.55B |
| Effective Tax Rate | 10.74% |
Stock Price Statistics
The stock price has decreased by -18.94% in the last 52 weeks. The beta is 0.50, so NH Nongwoobio's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -18.94% |
| 50-Day Moving Average | 6,871.80 |
| 200-Day Moving Average | 7,598.15 |
| Relative Strength Index (RSI) | 59.43 |
| Average Volume (20 Days) | 13,605 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NH Nongwoobio had revenue of KRW 160.53 billion and earned 12.97 billion in profits. Earnings per share was 808.73.
| Revenue | 160.53B |
| Gross Profit | 76.44B |
| Operating Income | 10.75B |
| Pretax Income | 14.39B |
| Net Income | 12.97B |
| EBITDA | 17.09B |
| EBIT | 10.75B |
| Earnings Per Share (EPS) | 808.73 |
Balance Sheet
The company has 36.35 billion in cash and 25.86 billion in debt, with a net cash position of 10.49 billion or 654.55 per share.
| Cash & Cash Equivalents | 36.35B |
| Total Debt | 25.86B |
| Net Cash | 10.49B |
| Net Cash Per Share | 654.55 |
| Equity (Book Value) | 287.55B |
| Book Value Per Share | 17,894.58 |
| Working Capital | 169.17B |
Cash Flow
In the last 12 months, operating cash flow was 8.80 billion and capital expenditures -3.03 billion, giving a free cash flow of 5.78 billion.
| Operating Cash Flow | 8.80B |
| Capital Expenditures | -3.03B |
| Depreciation & Amortization | 6.35B |
| Net Borrowing | -2.74B |
| Free Cash Flow | 5.78B |
| FCF Per Share | 360.34 |
Margins
Gross margin is 47.62%, with operating and profit margins of 6.70% and 8.08%.
| Gross Margin | 47.62% |
| Operating Margin | 6.70% |
| Pretax Margin | 8.96% |
| Profit Margin | 8.08% |
| EBITDA Margin | 10.65% |
| EBIT Margin | 6.70% |
| FCF Margin | 3.60% |
Dividends & Yields
This stock pays an annual dividend of 220.00, which amounts to a dividend yield of 3.12%.
| Dividend Per Share | 220.00 |
| Dividend Yield | 3.12% |
| Dividend Growth (YoY) | 13.64% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 30.91% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 3.14% |
| Earnings Yield | 11.46% |
| FCF Yield | 5.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NH Nongwoobio has an Altman Z-Score of 2.93 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.93 |
| Piotroski F-Score | 5 |